- Tytuł:
- Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial
- Autorzy:
- Źródło:
- Infection: A Journal of Infectious Diseases. 51(5):1273-1284
Czasopismo naukowe